Patents by Inventor Catherine D. Van Raamsdonk

Catherine D. Van Raamsdonk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GNA11 mutations in melanoma
    Patent number: 8927215
    Abstract: The present invention provides methods of detecting mutations in a GNA11 gene in a melanocytic neoplasm for diagnostic and prognostic purposes. The invention further provides methods of treating such melanocytic neoplasm by modulating the activity of the mutated GNA11 gene.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: January 6, 2015
    Assignees: The Regents of the University of California, The University of British Columbia, The Board of Trustees of the Leland Stanford Junior University
    Inventors: Boris C. Bastian, Catherine D. Van Raamsdonk, Gregory S. Barsh
  • mutations in melanoma
    Patent number: 8501404
    Abstract: The present invention provides methods of detecting mutations in a Gnaq gene in a melanocytic neoplasm for diagnostic and prognostic purposes. The invention further provides methods of treating such melanocytic neoplasm by modulating the activity of the mutated Gnaq gene.
    Type: Grant
    Filed: February 8, 2008
    Date of Patent: August 6, 2013
    Assignees: The Regents of the University of California, The Board of Trustees of the Leland Stanford Junior University, The University of British Columbia
    Inventors: Boris C. Bastian, Catherine D. Van Raamsdonk, Gregory S. Barsh
  • GNA11 AND GNAQ EXON 4 MUTATIONS IN MELANOMA
    Publication number: 20130102653
    Abstract: The present invention provides methods of detecting activating mutations in exon 4 of a GNAQ or a GNA11 gene in a melanocytic neoplasm for diagnostic and prognostic purposes. The invention further provides methods of treating such melanocytic neoplasm by modulating the activity of the mutated GNAQ or GNA11.
    Type: Application
    Filed: April 15, 2011
    Publication date: April 25, 2013
    Applicants: The Univeristy of British Columbia, The Regents of the University of California
    Inventors: Klaus G. Griewank, Boris C. Bastian, Catherine D. Van Raamsdonk
  • GNA11 MUTATIONS IN MELANOMA
    Publication number: 20130058938
    Abstract: The present invention provides methods of detecting mutations in a GNA11 gene in a melanocytic neoplasm for diagnostic and prognostic purposes. The invention further provides methods of treating such melanocytic neoplasm by modulating the activity of the mutated GNA11 gene.
    Type: Application
    Filed: October 29, 2010
    Publication date: March 7, 2013
    Applicants: The Regents of the University of California, The Board of Trustees of the Leland Stanford Junior University, The University of British Columbia
    Inventors: Boris C. Bastian, Catherine D. Van Raamsdonk, Gregory S. Barsh
  • GNAQ MUTATIONS IN MELANOMA
    Publication number: 20110070221
    Abstract: The present invention provides methods of detecting mutations in a Gnaq gene in a melanocytic neoplasm for diagnostic and prognostic purposes. The invention further provides methods of treating such melanocytic neoplasm by modulating the activity of the mutated Gnaq gene.
    Type: Application
    Filed: February 8, 2008
    Publication date: March 24, 2011
    Inventors: Boris C. Bastian, Catherine D. Van Raamsdonk, Gregory S. Barsh